Page last updated: 2024-09-03

fluorescein-di-beta-d-galactopyranoside and 5-bromo-4-chloro-3-indolyl beta-galactoside

fluorescein-di-beta-d-galactopyranoside has been researched along with 5-bromo-4-chloro-3-indolyl beta-galactoside in 1 studies

Compound Research Comparison

Studies
(fluorescein-di-beta-d-galactopyranoside)
Trials
(fluorescein-di-beta-d-galactopyranoside)
Recent Studies (post-2010)
(fluorescein-di-beta-d-galactopyranoside)
Studies
(5-bromo-4-chloro-3-indolyl beta-galactoside)
Trials
(5-bromo-4-chloro-3-indolyl beta-galactoside)
Recent Studies (post-2010) (5-bromo-4-chloro-3-indolyl beta-galactoside)
28034230115

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flye, MW; Kennedy, S; Ponder, KP; Rettinger, S1

Other Studies

1 other study(ies) available for fluorescein-di-beta-d-galactopyranoside and 5-bromo-4-chloro-3-indolyl beta-galactoside

ArticleYear
Experiments in transgenic mice show that hepatocytes are the source for postnatal liver growth and do not stream.
    Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:1

    Topics: Acute-Phase Proteins; Animals; Animals, Newborn; Base Sequence; Cell Movement; Cell Separation; Flow Cytometry; Fluoresceins; Galactosides; Gene Dosage; Hepatectomy; Indoles; Liver; Methylation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; Oligonucleotide Probes; Spleen

1995